Winson Tang is the Vice President of Clinical Research at Sangamo Biosciences, Inc. and is a highly accomplished medical professional. He is trained in immunology as well as nephrology and has a strong interest in orphan diseases. He has therapeutic expertise in diabetes, oncology, hepatology, virology, immunology, and nephrology. He has worked on drug development for orphan diseases and he has worked in clinical research for many years. Drug research and development is an important part of the medical field. If you are interested in learning more about drug development, there are several facts that you may need to know.
Drug development involves several different steps. The first step involves research and discovery. A new medicine or therapy can ameliorate the patient’s symptoms as well as fewer hospitalizations and a higher quality of life. Scientist and doctors study illnesses and diseases in order to find new ways to treat and cure those maladies.
However, medical research can take years and it can be very expensive. According to PhRMA, “the average cost to research and develop each successful drug is estimated to be $2.6 billion,” but that amount “incorporates the cost of failures – of the thousands and sometimes millions of compounds that may be screened and assessed early in the R&D process, only a few of which will ultimately receive approval.” The research step can be difficult and expensive for pharmaceutical companies.
Recommended Post – Winson Tang MD – Important Innovations in Medical Drugs
The second step involves preclinical research. Once scientists discover a potential drug, they must proceed to laboratory testing. During the process, scientists strive to answer some basic questions about the safety of the drug. After scientists determine whether or not the drug is safe, they can move on to clinical trials.
This vital step involves human trials and research. Clinical research helps scientists determine how the drug interacts with the human body and how prevalent the side effects can be. Scientists and researchers put a lot of care and effort into designing a clinical research program. They determine what it is they want to accomplish during each Clinical Research Phase when they start the Investigational New Drug Process.
The fourth step in the drug development process involves sending the data to the United States Food and Drug Administration (FDA) for review. An FDA team analyzes the drug or device in order to determine its safety and whether or not it should be approved. The fifth step involves FDA monitoring.
The FDA watches the new drug or device once it is released to the public in order to make sure that it is safe for public use. Winson Tang is a knowledgeable and experienced medical professional in California. He works with various drug therapies and is responsible for clinical research programs at Sangamo Biosciences, Inc.